A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

rac-Mirabegron | CAS 1330277-46-7 - Request Quote

Picture of rac-Mirabegron

rac-Mirabegron

SZ CAT No:SZ-M035088
CAS No
1330277-46-7
Mol.F.
C21H24N4O2S
Mol.Wt.
396.5
Inv. Status
In Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

rac-Mirabegron is chemically 2-(2-Aminothiazol-4-yl)-N-(4-(2-((2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)acetamide. rac-Mirabegron is supplied with detailed characterization data compliant with regulatory guideline. rac-Mirabegron can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Mirabegron.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1330277-46-7

Purchase 1330277-46-7

Order 1330277-46-7

Enquire 1330277-46-7

price of 1330277-46-7

1330277-46-7 Supplier

1330277-46-7 Manufacturer

1330277-46-7 Exporter

buy high quality rac-Mirabegron

Purchase rac-Mirabegron

rac-Mirabegron suppliers

rac-Mirabegron manufacturers

rac-Mirabegron price

Order rac-Mirabegron

Enquire rac-Mirabegron

rac-Mirabegron cost

rac-Mirabegron Supplier

rac-Mirabegron Distributor

rac-Mirabegron for Method Validation

Mirabegron Reference Standard

rac-Mirabegron for ANDA Filing

rac-Mirabegron for Forced Degradation Studies

rac-Mirabegron Identification Standards

rac-Mirabegron for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,